Selection of phages that inhibit vWF interaction with collagen under both static and flow conditions

Thrombosis and Haemostasis

Volumn 86, Issue 2, 2001, Pages 630-635

  Ulrichts, H ^a   Depraetere, H ^a   Harsfalvi, J ^a   Deckmyn, H ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Phage display; Platelet adhesion; Von Willebrand factor

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; PEPTIDE; VON WILLEBRAND FACTOR;

ARTICLE; BINDING AFFINITY; CLONE; CONCENTRATION (PARAMETERS); FLOW; IC 50; INHIBITION KINETICS; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN INTERACTION; SHEAR RATE; THROMBOCYTE ADHESION;

EID: 0034910564     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616097     Document Type: Article

References (35)

1. Identification of a 160,000 dalton platelet membrane protein that mediates the initial divalent cation-dependent adhesion of platelets to collagen
2. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia
3. Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction
4. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency
5. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors
6. Platelet adhesion in health and disease
7. Von Willebrand factor and the blood vessel wall
8. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets
9. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow
10. Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions
11. Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not
12. Alpha 2 beta 1 integrin: A collagen receptor on platelets and other cells
13. Identification of putative ligand binding sites within I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29)
14. Direct binding of collagen to the I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) in a divalent cation-independent manner
15. The VLA-2 (alpha 2 beta 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: Molecular and functional characterization
16. The integrin alpha 2 beta 1 (GPIa/IIa)-I-domain inhibits platelet-collagen interaction
17. The superfamily of proteins with von Willebrand factor type A-like domains: One theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms
18. A3 domain is essential for interaction of von Willebrand factor with collagen type III
19. Synthetic peptides inhibit the interaction of von Willebrand factor-platelet membrane glycoproteins
20. Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin
21. The binding domain of von Willebrand factor to sulfatides is distinct from those interacting with glycoprotein Ib, heparin, and collagen and resides between amino acid residues Leu 512 and Lys 673
22. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor
23. Von Willebrand factor binds to native collagen VI primarily via its A1 domain
24. Identification of domains responsible for von Willebrand factor type VI collagen interaction mediating platelet adhesion under high flow
25. Von Willebrand factor without the A2 domain is resistant to proteolysis
26. Interaction of the von Willebrand factor (vWF) with collagen
27. Adhesive domains in the collagen III fragment alpha1(III)CB4 that support alpha2beta1- and von Willebrand factor-mediated platelet adhesion under flow conditions
28. Recombinant leech antiplatelet protein prevents collagen-mediated platelet aggregation but not collagen graft thrombosis in baboons
29. Recombinant leech antiplatelet protein specifically blocks platelet deposition on collagen surfaces under flow conditions
30. Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters
31. Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions
32. The collagen-binding leech products rLAPP and calin prevent both von Willebrand factor and alpha2-beta1(GPIa/IIa)-I-domain binding to collagen in a different manner
33. Identification of peptides, selected by phage display technology, that inhibit von Willebrand factor binding to collagen
34. Sequence alignment between vWF and peptides inhibiting the vWF-collagen interaction does not result in the identification of a collagen-binding site in vWF
35. A new and reproducible vWF-RiCof assay